JPMorgan Defending Kenvue Inc (KVUE): 'Tylenol products already direct patients who are pregnant or breastfeeding to consult their healthcare provider before use'
Tweet Send to a Friend
JPMorgan analyst Andrea Teixeira reiterated an Overweight rating and $24.00 price target on Kenvue Inc (NYSE: KVUE).The analyst comments "This ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
